th ocular oncology day - formazione ed · pdf file5th ocular oncology day chair: doris...
TRANSCRIPT
5th Ocular Oncology Day
Chair: Doris Hadjistilianou
Venue LocationHotel Garden2, Custoza st, 53100 Siena
RegistrationFor registrations, please visit the website: www.formazionedeventisrl.it.
CME AccreditationThis event has obtained from the Italian Ministry of Health, no. 9 CME Credits for:Orthoptists / Assistants in Ophthalmology, Nurses, Surgeons in: Oncology, Forensic Medicine Pediatrics, Ophthalmology, Neuroradiology, Radiotherapy and Genetic Medicine.The CME Credits will be awarded only to those who have:- Participated to the entire duration of the event- Completed the evaluation form of the event- Completed the CME questionnaire.
Organizing Secretary & CME Provider no. 447
3, Guadagnolo st, 00139 RomaTel: 06 87 188 886 / Fax: 06 87 192 213E-mail: [email protected] www.formazionedeventisrl.it
General Information
Siena, December 2nd-3rd, 2016Hotel Garden Sala Delle Camelie
Honorary PresidentsTero Kivela
Emilio Balestrazzi
Sponsored by
Ass. no pro� t “In fondo ai tuoi occhi”
Università degli studi di Siena
formazione ed eventi
International BoardL. Zografos, F. Munier, H. Kiratli, D. Gombos, M. Jager,
A.Schallenburg, T. Kivela, R. Aljamal, M. Popovic, A. Moll, S. Saakyan , A. Amiryan, P. De Graaf , M. De Jong
Local commetteeM. Blasi, C. Mosci, L. Pierro, V. Mazzeo, C. Mazzini
AIEOP BoardC. Favre, F. Fagioli, M.L. Garrè, R. Cozza, E. Basso,
A. Castellano, D. Galimberti, A. Tamburini
Scientifi c SecretaryM. Borri, G. Coriolani, S. De Francesco, G. Esposti
Angi M.Ariani F.Bacci T.Balestrazzi A.Balestrazzi E.Blasi M.A.Borri M.Bracco S.Brombin A.Caini M.Capozzoli M.Caputo R.Castellano A.Cennamo G.Chiarotti I.Coriolani G.Cozza R.De Francesco S.Esposti G.Fazio S.Fusco F.Cennamo G. Galimberti D.Galluzzi P.Garrè M. L.Guglielmucci D.Hadjistilianou D.Imperatore V.Litasova Y.
RelatoriMaestrini L.Martino F.Mazzeo V.Mazzini C.Mellace P.Menicacci F.Miele A.Monti L.Mora P.Mosci C.Neri G.Nucci P.Oldani B.Pagliara M.Pavese L.Pecorella I.Pieretti G.Pierro L.Pinto A.M.Rana F.Renieri A.Romanzo A.Russo I.Scaramuzzi M.Serafi no M.Sergenti J.Tarantello A.Tedesco S.Valente P.
Aljamal R.
Amiryan A.
Andreeva T.
Cohen V.
De Graaf P.
De Jong M.
Galley M. T.
Gombos Dan S.
Ivanova O.
Jager M.
Kiratli H.
SpeakersKivela T.
Marinkovic M.
Moll A.
Munier F.
Patel S.P.
Popovic M.
Saakyan S.
Schallenburg A.
Thomas A.
Vishnevskia-Dai V.
Zografos L.
14:00 Registration
CASE REPORTSModerators: R. Caputo, V. Mazzeo, C. Mazzini
14:30 Iris melanoma in a child: local treatment and long-term follow-up results S. V. Saakyan, O. Ivanova MOSCA
14:35 The neverending vs ending stories of three uveal melanomas. one more year follow-up V. Mazzeo, L. Lodi, BOLOGNA-FERRARA
14:40 Co-existence of intraocular and orbital lymphoma: does it rare condition? A. G. Amiryan, T. Andreeva MOSCA
14:45 Retinal astrocytic hamartoma: optical coherence tomography classifi cation and correlation with tuberosis sclerosis complex M. Scaramuzzi, M. Serafi no, P. Nucci MILANO
14:50 A rare case of multiple recurrent conjunctival malignant melanoma during 27 years. An. Balestrazzi, I. Giannico, I. Pecorella, E. Balestrazzi GROSSETO-ROMA
14:55 Conjunctival melanoma during pregnancy R. Aljamal LONDON
15:00 Mutational analysis in a patient with uveal and cutaneous melanoma DS. Gombos, S. Patel HOUSTON
15:05 Complex combined therapy for relapsed conjunctival melanoma G. Pieretti, A. Miele, N. Santoro, S.Rizzo, C. Mazzini FIRENZE
15:10 Masquerade syndrome in childhood: a tricking case S. Tedesco, P. Mora PARMA
15:15 OCT angiography in the diagnosis and follow up of choroidal tumors G. Cennamo NAPOLI
Friday December 2nd 15:20 The accordion SMCL V. Mazzeo, L. Lodi BOLOGNA-FERRARA
15:25 Eyelid lesion in a 4-year-old boy: a tricky case J. Sergenti, C. Bertone, M. Zecca, P. E. Bianchi PAVIA
15:30 Osteoma of the choroid G. Esposti, S. De Francesco SIENA
15:35 Diff erential diagnosis of peripheral exudative haemorrhagic chorioretinophaty (pehcr) in adult patient P. Mora, S. Tedesco PARMA
15:40 An accidental diagnosis of a rare intarorbital tumor - a multidisciplinary approach M. Pasti, B. Zamma Gallarati, C. De Libero, F. Mussolini, R. Caputo FIRENZE
15:45 Discussione
16:00 SESSION 1: Immunology in Ocular Oncology Moderators: M. Jager, S. P. Patel 16:00 Invited Lecture: Immunology and therapy in uveal melanoma M. Jager LEIDEN
16:20 Resistance to immune therapy in uveal melanoma S.P. Patel HOUSTON
16:40 SESSION 2: Filming the Intraarterial Chemotherapy Moderators: S. Bracco, D. Hadjistilianou, D. Gombos16:40 The IA story in progress S. Bracco, S. Cioni, P. Gennari, D. Romano, I. Vallone SIENA16:48 IA experience in Padua F. Causin PADOVA
16:56 Toxicities reported with intra-arterial chemotherapy for retinoblastoma Ds. Gombos, E. Shortridge HOUSTON
17:04 Conclusions D. Hadjistilianou SIENA
P
R
O
G
R
A
M
17:20 SESSION 3: Nursing in Ocular Oncology Moderators: M.T. Galley, L. Maestrini17:20 Nursing management of patients receiving intraarterial chemotherapy M. T. Galley, A. Thomas LAUSANNE
17:27 Retinoblastoma: life stories L. Maestrini, C. Begani SIENA
Saturday December 3rd
08:00 Opening Ceremony
08:30 Invited Lecture: Nevus versus uveal melanoma T. Kivela HELSINKI
09:00 SESSION 4: Uveal Melanoma Moderators: E. Balestrazzi, M. Blasi, C. Mosci09:00 Uveal melanoma with optic nerve invasion MM. Pagliara, MA. Blasi ROMA
09:06 Long-term visual acuity preservation after proton therapy for parapapillary melanoma A. Schalenbourg, A. Pica, J. Hrbacek, H. Wagner, L. Vallat, C. Bergin, Dc. Weber, L. Zografos LAUSANNE
09:12 Stereotactic radiosurgery in uveal melanoma A. Miele, G. Pieretti, S. Rizzo, C. Mazzini FIRENZE
09:18 New frontiers in the radiotherapy of uveal melanoma C. Mosci GENOVA
09:24 Our experience in leiden with ruthenium with or without TTT in uveal melanoma M. Marinkovic LEIDEN
09:30 Prognostic biopsy in uveal melanoma: why, when and how? M. Angi MILANO
09:36 Familial and hereditary uveal melanomas T. Kivela HELSINKI
09:42 Extraocular extension of uveal melanoma: diagnosis and management V. Cohen LONDON
09:48 Optical density ratio of the sub-retinal fl uid in choroidal melanoma and metastasis as a novel additional diagnostic tool V. Vishnevskia-Dai, A. Leshno, A. Barak, D. Zur, Sh. Gabai, I. Moroz, M. Neudorfer TEL AVIV 09:54 I125 brachytherapy and vitrectomy in the treatment of uveal melanoma complicated with vitreous hemorrhage. F. Genovesi-Ebert, E. Di Bartolo, F. Cresti PISA10:00 Discussion10:10 Key Note Lecture: Contribution of modern multimodal imaging techniques in the management of uveal melanomas L. Zografos LAUSANNE 10:30 Coff e break10:45 SESSION 5: Imaging in Ocular Oncology Moderators : A. Moll, H. Kiratli, L. Pierro10:45 The role of SD-OCT in the diagnosis and management of intraocular tumors H. Kiratli ANKARA 10:52 A novel handheld optical frequency domain 1050nm imaging system: clinical study with pediatric retinoblastoma patients A. Moll, C. Nadiarnykh, N. Mcneill, M.I. Bosscha, P. De Graaf, F. Verbraak, J.F. De Boer AMSTERDAM10:59 The role of color doppler imaging in distinguishing malignant from benign eye lesions L. Monti, I. Chiarotti, P. Galluzzi SIENA 11.06 Choroidal osteoma, angioOCT diff erent patterns L. Pierro MILANO 11:10 Discussion11:25 Invited Lecture Role of anti-VEGF therapy in the management of retinoblastoma F. Munier LAUSANNE11:45 SESSION 6: MRI in Ocular Oncology Moderators: A. M. Pinto, L. Monti, P. De Graaf11:45 The value of dynamic contrast enhanced and diff usion weighted imaging in planning the right treatment in retinoblastoma patients P. Galluzzi SIENA
P
R
O
G
R
A
M
11:51 MRI-based assessment of the pineal gland in a large population of children aged 0–5 years and comparison with pineoblastoma M. De Jong AMSTERDAM
11:57 Radiogenomics in retinoblastoma R. W. Jansen, M. C. De Jong, I. E. Kooi, S. Sirin, S. Göricke, H. J. Brisse, P.Maeder, P. Galluzzi, P. Van Der Valk, J. Cloos, I. Eekhout, J. A. Castelijns1 , A. C. Moll, J. C. Dorsman, P. De Graaf AMSTERDAM
12:05 Discussion
12:40 Lunch
14:00 SESSION 7: Chemo regimens in ocular oncology Moderators: M. Popovic, E. Basso D. Galimberti
14:00 The role of adjuvant systemic chemotherapy in advanced retinoblastoma with histologic risk factors after primary enucleation D. Galimberti, D.F. Guglielmucci, M. Caini, G. Coriolani, F. Carra, S. Grosso SIENA
14:07 “RTB AIEOP 012”: Presentation of the new regimen of treatment I. Russo ROMA
14:14 Treatment-related general side eff ects: a comparison between intravenous and intraarterial therapy in retinoblastoma M. Popovic LAUSANNE
14:21 Successes and failures of combined intra-arterial and intravitreal chemotherapy: a four years experience D. Hadjistilianou , S. De Francesco, M. Borri SIENA
14:28 Discussion
15:00 SESSION 8: Extraocular retinoblastoma Moderators: R. Cozza, A. Castellano, A. Tamburini
15:00 Update on extraocular retinoblastoma: current and innovative treatment strategies I. Russo ROMA
15:07 Extraocular retinoblastoma:response to intensivechemotherapyand outcome in 4 cases M. L. Garre, E. Lanino, G. Morana, P. Capris GENOVA
15:14 Extraocular retinoblastoma: an unusual case D. Hadjistilianou, G. Coriolani, D. Galimberti, E. Basso, D. Guglielmucci, F. Carra, M. Caini, P. Galluzzi, P. Toti SIENA15:21 Discussion
15:30 SESSION 9: Retinoblastoma and More Moderators: T. Kivela, F. Munier15:30 Cytology of aqueous fl uid and ocular washings following intravitreal injection of chemotherapy for retinoblastoma DS. Gombos, E. Shortridge, M. Chintagumpala, C. Herzog, P. Chevez-Barrios HOUSTON
15:35 Massive optic nerve invasion in retinoblastoma D. Hadjistilianou, G. Coriolani, P. Galluzzi, S. Defrancesco, M. Borri, D. Galimberti, M. Caini, D. Guglielmucci SIENA
15:40 Familiar neonatal retinoblastoma: a case of inappropriate Management. A. Romanzo ROMA
15:45 The role of enucleation in radiologically detectable optic Nerve Invasion: A Case Series P. Valente ROMA
15:50 Reasons for late relapses of retinoblastoma S. V. Saakyan, T. A. Andreeva MOSCA
15:55 Intravitreal melphalan and topotecan in the management of vitreous disease in retinoblastoma (our experience on some 40+ patients) H. Kiratli ANCARA
16:00 1Parent inheritance of rb1 hypomorphic mutations and somatic mosaicism can explain low penetrance in retinoblastoma V. Imperatore, A. M.Pinto, E. Gelli, E. Trevisson, C. Lo Rizzo, V. Morbidoni, G. Roversi, L. Dosa, S. Amitrano , S. Somma, M. Bruttini, P. Toti, M. F. Antonucci, T.Hadjistilianou, S. De Francesco, E. Gusson, M. A. Mencarelli, F. Mari, A. Renieri , F. Ariani SIENA
16:05 The “does” and “does not” in surgery for intraocular pediatric tumors F. Menicacci, S. Defrancesco, F. Neri, C. Menicacci, D. Hadjistilianou SIENA
16:10 Discussion
P
R
O
G
R
A
M
16:30 SESSION 10: Residents Session: rapid fi re presentations Moderators: G. Chimenti, M. Borri, D. Hadjistilianou
16:30 Melanocytoma of the ciliary body in a child F. Fusco, F. Martino, D. Hadjistilianou, M. Borri, S. De Francesco, B. Colucci SIENA
16:34 Coats disease and norrie disease in the same family A. Tarantello, T. Bacci, L. Mazzera, R. Caputo SIENA
16:38 Amartoma of the optic disk S. Fazio, Y. Litasova, F. Rana SIENA
16:42 Mystery Case G. Esposti, S. De Francesco, M. Borri, L. Zografos SIENA
16:46 Retinoma and controlateral malignant transformation of retinoma M. Capozzoli, P. Mellace, B. Oldani TORINO-SIENA
17:00 Retinoblastoma or medulloepithelioma? D. Hadjistilianou, G. Neri, E. Latronico, L. Pavese, A. Brombin MODENA-SIENA
P
R
O
G
R
A
M
Notes
_____________________________
_____________________________
_____________________________
_____________________________
_____________________________
_____________________________
_____________________________
_____________________________